Emerald Advisers, LLC Assembly Biosciences, Inc. Transaction History

Emerald Advisers, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 29, 2021	SELL	$4.87 - $17.29 $1.55 Million - $5.49 Million	-317,704 Closed	0 $0
Q3 2020 Oct 28, 2020	SELL	$15.08 - $27.04 $1.88 Million - $3.36 Million	-124,341 Reduced 28.13%	317,704 $5.22 Million
Q2 2020 Jul 28, 2020	BUY	$14.57 - $23.96 $70,227 - $115,487	4,820 Added 1.1%	442,045 $10.3 Million
Q1 2020 Apr 30, 2020	BUY	$10.27 - $21.23 $14,799 - $30,592	1,441 Added 0.33%	437,225 $6.48 Million
Q4 2019 Jan 29, 2020	SELL	$8.36 - $23.81 $8,610 - $24,524	-1,030 Reduced 0.24%	435,784 $8.92 Million
Q3 2019 Oct 31, 2019	SELL	$9.83 - $14.82 $251,716 - $379,495	-25,607 Reduced 5.54%	436,814 $4.29 Million
Q2 2019 Jul 31, 2019	SELL	$12.9 - $20.8 $76,858 - $123,926	-5,958 Reduced 1.27%	462,421 $6.24 Million
Q1 2019 May 01, 2019	BUY	$17.7 - $24.93 $1.4 Million - $1.97 Million	79,039 Added 20.3%	468,379 $9.22 Million
Q4 2018 Jan 30, 2019	SELL	$19.05 - $36.45 $133,159 - $254,785	-6,990 Reduced 1.76%	389,340 $8.81 Million
Q3 2018 Oct 31, 2018	BUY	$34.41 - $44.23 $5.61 Million - $7.21 Million	162,943 Added 69.82%	396,330 $14.7 Million
Q2 2018 Jul 31, 2018	BUY	$39.21 - $50.29 $4.14 Million - $5.31 Million	105,552 Added 82.57%	233,387 $9.15 Million
Q1 2018 Apr 26, 2018	SELL	$41.7 - $64.16 $2.66 Million - $4.1 Million	-63,830 Reduced 33.3%	127,835 $6.28 Million
Q4 2017 Feb 05, 2018	BUY	$28.58 - $49.91 $5.48 Million - $9.57 Million	191,665	191,665 $8.67 Million

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $716M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of Emerald Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Emerald Advisers, LLC with notifications on news.